US20170065696A9 - Novel method for preventing or treating m tuberculosis infection - Google Patents

Novel method for preventing or treating m tuberculosis infection Download PDF

Info

Publication number
US20170065696A9
US20170065696A9 US14/603,935 US201514603935A US2017065696A9 US 20170065696 A9 US20170065696 A9 US 20170065696A9 US 201514603935 A US201514603935 A US 201514603935A US 2017065696 A9 US2017065696 A9 US 2017065696A9
Authority
US
United States
Prior art keywords
sequence
polypeptide
mtb72f
sequences
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US14/603,935
Other versions
US9655958B2 (en
US20150231224A1 (en
Inventor
Rhea Coler
Steven Reed
Yves Lobet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US67654905P priority Critical
Priority to US77701706P priority
Priority to PCT/EP2006/004319 priority patent/WO2006117240A2/en
Priority to US91273008A priority
Priority to US13/895,574 priority patent/US9056913B2/en
Priority to US14/603,935 priority patent/US9655958B2/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Assigned to INFECTIOUS DISEASE RESEARCH INSTITUTE reassignment INFECTIOUS DISEASE RESEARCH INSTITUTE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: REED, STEVEN, COLER, RHEA
Assigned to GLAXOSMITHKLINE BIOLOGICALS reassignment GLAXOSMITHKLINE BIOLOGICALS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOBET, YVES
Assigned to GLAXOSMITHKLINE BIOLOGICALS SA reassignment GLAXOSMITHKLINE BIOLOGICALS SA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INFECTIOUS DISEASES RESEARCH INSTITUTE
Publication of US20150231224A1 publication Critical patent/US20150231224A1/en
Assigned to GLAXOSMITHKLINE BIOLOGICALS S.A. reassignment GLAXOSMITHKLINE BIOLOGICALS S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MARCHAND, MARTINE
Publication of US20170065696A9 publication Critical patent/US20170065696A9/en
Publication of US9655958B2 publication Critical patent/US9655958B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links